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Summary 
Within the field of public health, and increasingly across other areas of social policy, there 
are widespread calls to increase or improve the use of evidence for policy making. Often 
these calls rest on an assumption that improved evidence utilisation will be a more efficient 
or effective means of achieving social goals. Yet, a clear elucidation of what can be 
considered ‘good evidence’ for policy use is rarely articulated. Many of the current 
discussions of best practice in the health policy sector derive from the evidence-based 
medicine (EBM) movement, embracing the ‘hierarchy of evidence’ in framing the selection 
of evidence – a hierarchy that places experimental trials as preeminent in terms of 
methodological quality. However, there are a number of difficulties associated with applying 
EBM methods of grading evidence onto policy making. Numerous public health authors 
have noted that the hierarchy of evidence is a judgement of quality specifically developed 
for measuring intervention effectiveness, and as such it cannot address other important 
health policy considerations such as affordability, salience, or public acceptability (Petticrew 
and Roberts, 2003).  
Social scientists and philosophers of knowledge have illustrated other problems in the direct 
application of the hierarchy of evidence to guide policy. Complex or structural interventions 
are often not conducive to experimental methods, and as such, a focus on evidence derived 
from randomised trials may shift policy attention away from broader structural issues (such 
as addressing the social determinants of health (Solar and Irwin, 2007)), to disease 
treatment or single element interventions. Social and behavioural interventions also present 
external validity problems to experimental methods and meta-analyses, as the mechanisms 
by which an intervention works in one social context may be very different or produce 
different results elsewhere (Cartwright, 2011). In these cases, policy makers may be better 
advised to look for evidence about the mechanism of effect, and evidence of local 
contextual features (Pawson et al., 2005).  
We argue that rather than adhering to a single hierarchy of evidence to judge what 
constitutes ‘good’ evidence for policy, it is more useful to examine evidence through the 
lens of appropriateness. It is important to utilise evidence to improve policy outcomes, yet 
the form of that evidence should vary depending on the multiple decision criteria at stake. 
Policy makers must therefore start by articulating their decision criteria in relation to a given 
problem or policy, so that the appropriate forms of evidence can be drawn on – from both 
epidemiological and clinical experiments (e.g. for questions of treatment effect), as well as 
from social scientific, social epidemiological, and multidisciplinary sources (e.g. for questions 
of complex causality, acceptability, human rights, etc.). Following this selection of types of 
evidence on the basis of appropriateness, the rigour and quality of the research can be 
assessed according to the evidentiary best practice standards of the discipline within which 
the evidence was produced. This approach speaks to calls to improve the use of evidence 
through ensuring rigour and methodological quality, yet recognises that good evidence is 
dictated by specific public health or social policy goals. 
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Introduction 
The introduction of the concept of evidence-based policy has marked an important shift in 
policy processes. The health sector has particularly embraced this idea, in part because of 
the easy analogy with the evidence-based medicine movement (EBM), which has driven 
many of the current ways of using evidence within policy (Cookson, 2005, Berridge and 
Stanton, 1999). It is now generally acknowledged that the using research evidence to inform 
policy making can produce more efficacious results.  
However, the use of evidence within policy is as yet an unclear process. Previously, it had 
been thought that policy makers could draw directly upon research evidence where 
necessary, or conversely, that researchers could present and gear research in a way that 
optimises its adoption by policy makers. Early work on ‘knowledge transfer’ implied, as the 
term suggests, that the process was one of simply transferring the knowledge produced by 
researchers in a policy-useful format. Following from this, a wide range of efforts have been 
undertaken to increase the linkages between researchers (or their research findings) and 
decision makers (see Lavis et al., 2003, Mitton et al., 2007 for summeries of the knowledge 
translation literature). Further explorations suggested that ‘bridging the gap’ between the 
worlds of research and policy is not always straight-forward (see also Greenhalgh and 
Wieringa, 2011 for a critique of the concept). It has been noted, moreover, that the linear 
understanding of the evidence-to-policy process does not adequately account for the 
complexities and political nature of policy making (Bowen and Zwi, 2005). There are many 
factors, inherent within the political process of policy making, which might complicate the 
use of research evidence. Similarly, it is also important to note that research is often not 
produced in a way that is readily consumable for policy actors (Lavis, 2006, Lavis et al., 
2003). The goals of academic researchers do not necessarily translate directly to the goals of 
policy makers. An additional problem lies in understanding which pieces of evidence (i.e. 
bodies of literature or particular studies) might be useful for any particular policy problem. 
Such issues frame the focus of the following discussion. 
This working paper summarises existing ideas surrounding the good use of evidence. It 
focuses upon the current primacy of models which emphasise techniques drawn from 
evidence-based medicine (EBM), and the ‘hierarchy of evidence’ that EBM relies upon. It is 
shown that existing models of best practice tend to emphasise certain methodological 
elements (which favour experimental approaches) as critical to the ranking of quality 
evidence. The paper then explores critical voices from within public health, but also from 
sociologists and philosophers of science, on the issue of evidence use. These commentators 
point out that the forms of evidence highlighted as superior by the hierarchy of evidence are 
based upon a narrow view of methodological quality, specifically designed to address 
questions of intervention effect, and do not help to answer many questions which have 
social, cultural, or political dimensions. Instead, other bodies of evidence may be more 
appropriate to answering those questions, each with their own criteria for quality.   
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This paper attempts to explain some ways in which the use of evidence can be improved, 
taking into account existing critiques, but in a way that is practical and useful for public 
health planners. It proposes that the best use of evidence in decision-making does not 
simply focus upon quality as judged by the hierarchy of evidence. Rather, it is more useful to 
judge the appropriateness of the evidence type in respect to the considerations of the 
decision-maker. We suggest that the first step in the appropriate utilisation of evidence 
should therefore be the explicit articulation of policy objectives and decision-making criteria 
– both the biomedical and the broader social-political or economic concerns linked to a 
health policy decision. Following this, evidence should be selected on the basis of its 
appropriateness to the particular policy objectives, allowing for a more accurate matching of 
evidence to policy needs. Only after this should the evidence be assessed in terms of 
methodological rigour, based upon the type of evidence selected.  
 
 ‘Best practice’ as a hierarchy of evidence 
Current approaches to the use of evidence in policy have been drawn from the tradition of 
evidence-based medicine (EBM). The EBM movement highlights the importance of using 
evidence (particularly epidemiological evidence) to shape clinical decision-making (Canadian 
Taskforce on the Periodic Health Examination, 1994, Evidence-Based Medicine Working 
Group, 1992), and has been geared towards, and best applied to, questions of treatment 
efficacy.  
The dominant model for assessing evidence within EBM is drawn from the ‘hierarchy of 
evidence’ from the natural sciences. This hierarchy sets out the process though which 
research evidence can be evaluated. Forms of evidence that most adhere to the ideals of 
experimental conditions (as given in the natural sciences) are set at the ‘top’ of the 
hierarchy. These are methods which display key characteristics which include: large and 
representative sample size, control for experimenter and participant bias (often in the form 
of blinding, or preferably, double-blinding); control for external variables (i.e. studying the 
problem within a laboratory environment and/or use of a control arm to exclude 
confounding variables); the study of a singular experimental variable (to determine direct 
cause- effect relationships); and value-neutrality (i.e. the idea that the researcher must not 
be intent on a certain outcome, or let their subjective ideas impact on the research process) 
(Merton, 1973). 
It is understood that for clinical interventions, these factors are best constituted in the form 
of the Randomised Controlled Trial (RCT). Randomisation is understood to overcome the 
problem of confounding, by ensuring that any significant difference observed between 
subject groups is only due to the experimental variable/intervention. Experimental trials 
also attempt to minimise bias from either the researcher (particularly in double-blind 
conditions, where the research themselves do not know which research subjects were 
treated and which were the control group) and subject bias (again through blinding, since 
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research subject may tend to unconsciously behave in certain ways to please researchers or 
otherwise skew research results) (Chalmers et al., 1981). The use of a placebo (i.e. in the 
control group of subjects) also lets researchers account for the placebo effect, or the extent 
to which simply being studied achieves a change in behaviour or state. 
Non-experimental methods - such as case studies, observational data, or case-controlled 
studies – are seen as less useful forms of intervention research, due to their inability to 
control for confounding variables, and the greater potential for bias to be introduced as 
some stage in the research protocol. However, these forms of research can also be more or 
less rigorous, depending for example upon sample size, representativeness, and other 
qualities of the methods employed (Borgerson, 2009).  
The norms of good scientific method, as illustrated above, define which types of research 
are considered ‘best’ in relation to the hierarchy of evidence, and what ‘rigour’ means in the 
context of these types of research. The way in which the hierarchy is described can differ 
slightly between organisations and commentators. However a simplified hierarchy consists 
of the following: 
1. Systematic reviews and meta-analysis of Randomised Controlled Trials (RCTs) 
2. RCTs with definitive results (large and well-conducted studies) 
3. RCTs with non-definitive results (including smaller RCTs) 
4. Cohort studies 
5. Case control studies 
6. Case studies 
7. Expert opinion 
(see Nutley et al., 2012 for variations on the hierarchy) 
Though these categories are somewhat variable, all representations emphasise large, 
randomised and well-controlled trials as the gold-standard of research. For example, in the 
UK, the National Institute of Health and Clinical Excellence (NICE) provides guidelines to the 
National Health Service, and has its own hierarchy of evidence to grade the quality of 
evidence for its recommendations (see for example NICE, 2004). This is integrated with cost-
effectiveness studies to produce recommendations, which are awarded ‘grades’ depending 
upon the strength of their sources, with ‘A’ recommendations being based directly on RTCs 
or meta-analyses of RTCs to ‘D’ recommendations based upon expert opinion or inferences 
from upper-level studies (NICE, 2005: 11.5).  
There are also a number of other bodies using similar hierarchies to guide health policy and 
practice. The GRADE (Grading of Recommendations, Assessment, Development and 
Evaluation) working group, for example, is an international body that aims to develop a 
more universal mechanism to grade evidence of health interventions to develop 
recommendations. GRADE (2013) evaluates biomedical evidence upon the basis of risk, 
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burden, and cost of intervention. This brings in some non-biomedical factors (e.g. cost of 
intervention), but again the initial approach is still to judge evidence from RCTs as high 
quality, from observational data as low quality, and other methods as very low quality.  
Similarly, the Strength of Recommendations Taxonomy (SORT) (Ebell et al., 2004), formed by 
a consortium of family medicine practitioners and academics, is aimed at helping physicians 
navigate the process of EBM by assessing the quality, quantity and constitution of evidence 
based upon EBM hierarchies of evidence. A further example of the way in which EBM 
techniques has been formalised is through the Centre for Evidence Based Medicine (CEBM), 
run through Oxford University, which is designed to aid physicians, researchers and patients 
to understand EBM approaches (2013). CEBM guidelines go a long way in qualifying the use 
of these approaches (i.e. in explicitly cautioning that whole-population based approaches do 
not straight-forwardly indicate what might be best for an individual patient). Despite this, 
common to all of these approaches is the way in which the methodological superiority of 
experimental evidence, and hierarchies of evidence formed around this, are taken for 
granted (see also Annex 1 of Nutley et al., 2012 for other examples of evidentiary 
management bodies).  
What is clear in these formulations of ‘best’ evidence is the fact that certain research 
methodologies are placed above others. Particularly privileged are randomised trials, and 
combinations of multiple randomised trials which show consistent effects. This way of 
evaluating evidence is useful in so much as it allows policy makers to easily sift through large 
amounts of research and identify the most rigorous pieces (Cook et al., 1997, Mulrow, 
1994). However, many commentators have also pointed out potential flaws in this 
technique, for example where small studies, conducted in particular contexts, are combined 
in a way that skews results (Black, 2001).  
More fundamentally, evidence evaluation techniques which are based upon EBM take for 
granted that evidence can be assessed in relation to its methodological ‘quality’, as defined 
by the norms of the natural sciences. These methods presuppose that causal mechanisms 
are constant over place and time. This also assumes that taking a research problem out of 
its context is the best way of understanding it (and this assumption, as we will show below, 
that can often be problematic).  
The establishment of these rankings of evidence have typically grown out of a concern for 
ensuring that practice – particularly clinical practice – follows the best available evidence of 
effectiveness. However, these hierarchies are increasingly being applied in policy circles. The 
shift in terminology from evidence based medicine to evidence based policy has equally 
seen attempts to call for policy decisions to also apply such hierarchies of evidence to their 
decision making. Yet this raises a number of critical questions.  
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The importance of non-clinical outcomes in policy decisions 
Policy making often involves deciding between competing sets of decision criteria. Health 
policies may be decided on the evidence of clinical effect of an intervention, but decision 
makers equally may wish to consider the social acceptability of that intervention, or the 
impact it will have not just on morbidity and mortality outcomes, but on other socially 
valued concerns, such as equity, justice or human rights. Many health policy decisions are 
not simply about clinical and biomedical interventions, but may involve social and 
organisational interventions for which these hierarchies were not originally developed.  
Even within the field of public health there have been voices pointing to the misuse of 
evidence hierarchies to inappropriate questions (Booth, 2010, Petticrew and Roberts, 2003). 
As Glaszou and colleagues explain, “different types of question require different types of 
evidence” (2004: 39). For most policy making situations, the different types of questions go 
beyond clinical and immediate health related issues, to involve areas of social, political or 
economic concern. RCTs are not always useful for questions that do not speak directly to 
clinical efficacy, and have been criticised for being applied uncritically, even within the 
biomedical sciences (for example, in investigating disease aetiology rather than treatment 
options) (Glasziou et al., 2004, Green and Glasgow, 2006). The external validity of many 
RCTs, indicating the usefulness of the research in the context of different patient 
demographics, is often not well-articulated (Rothwell, 2005). Further, causality is often a 
complex process, and RCTs are not necessarily helpful in situations where multiple causal 
factors might be implicated (Victoria et al., 2004).  As such, calls for methodological aptness 
(Pettigrew, 2003), and a context-based selection of evidence (Boaz and Ashby, 2003, 
Dobrow et al., 2004) are now coming to the forefront. 
Political scientists have long noted the multiple competing values and issues around which 
policy decisions are made, pointing to the need for policy makers to consider multiple 
bodies of evidence, including evidence surrounding social values and norms. These will not 
come from experimental methods. Rather, such evidence will come from methods which 
seek to understand (rather than seek to control for) the social context (Petticrew and 
Roberts, 2003, Bowen and Zwi, 2005). Policy interventions with social components, or which 
seek out social change, need to look at forms of research which provide information on the 
social (rather than natural) world.  
 
Hierarchies of intervention effectiveness do not well-inform many 
important policy goals 
The sociology of health highlights the fact that ill-health is often structured by gradients of 
socio-economic status (Wilkinson, 2002, Wilkinson and Marmot, 2003), gender (Courtenay, 
2000, Doyal, 2000), geographical location (Haynes and Gale, 2000), or other social variables. 
If public health officials ultimately strive to alleviate ill-health, or identify the cause of ill-
health, it may be useful for them to utilise evidence from research on social variables, much 
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of which is not experimental in nature. For example, diabetes mellitus is enduring as an 
important chronic health problem in countries which have undergone the epidemiological 
transition into chronic disease prevalence. In accounting for diabetes through policy, 
decision-makers might find it useful to seek out clinical evidence on risk factors and 
treatments. However, policy making might also seek to target at-risk populations and 
communities. In order to do this, research that explores the social distribution of diabetes 
can help policy makers understand the problem further and provide as much, if not more, 
useful evidence to inform decisions as experiments of interventions to treat or prevent 
diabetes. These may rigorously test the effectiveness of specific interventions, but do not 
speak to the socio-political considerations of relevance. Clinical effectiveness evidence may 
also unduly focus policy makers on treatment over prevention, particularly when causes are 
complex and socially rooted. Looking at the literature surrounding the social gradient of 
diabetes illustrates that its incidence is structured by sex, ethnicity, socio-economic status 
and other social factors (McKinlay and Marceau, 2000, Young et al., 1990). This type of 
research evidence might therefore be more important to guide the management of this 
disease in the long-term. 
As suggested within the sociology of scientific knowledge, the existing hierarchies of 
evidence are based upon an understanding of health and illness as purely biological 
phenomena (Goldenberg, 2006). As a result, they highlight studies that seek out biological 
universals (that is, in seeing all bodies as fundamentally the same, they try and omit 
confounding variables in the study of biological processes). However, even if though 
biochemistry and anatomy may be fairly consistent, human behaviour, socio-cultural values, 
and social and political structures are widely variable. As the sociology of health and illness 
illustrates, there are many social factors that impact upon health and healthcare. For 
example, healthcare generally occurs within the confines of professional and institutional 
structures. Understanding these structures can therefore be useful to understanding the 
way in which health outputs can be optimised. 
A simple example of health service management helps to illustrate: If a Ministry of Health 
wants to improve the flow of patients within public hospital emergency rooms, they can 
think of several ways in which this can be achieved (for example, increasing the number of 
emergency room beds, modifying the way in which patients are triaged etc.), all with 
distinct economic and political advantages and disadvantages. When looking at this 
question, experimental forms of research are feasible – one could randomly allocate some 
hospitals to have more beds, others to have different triage processes, and others as 
controls. Yet the complexity of the causal mechanism may mean that such experiments on 
single variables may not adequately address the policy problem.  Experiments varying single 
components of a complex system may be less useful than efforts aimed to better 
understand the structure and organisation of emergency rooms as a systemic whole. One 
way to do this could be through observational research. For example observational studies 
look at the way in which patients ‘flow’ through hospital systems. For instance, Nugus and 
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colleagues find that efficient flow of patients depends on many factors, including the 
mobilisation of personal and professional influence, hospital management structures, as 
well as ways in which staff on non-emergency wards perceive and/or guard the ‘space’ left 
on their ward (Nugus and Braithwaite, 2010, Nugus et al., 2009, Nugus et al., 2010). 
Similarly, mathematical models of patient flow, or interview data on health workers’ 
experience of patient flow in the A&E may help make the situation more clear to policy 
makers. The intervention decision may therefore be based on a tailored approach based on 
understanding of system dynamics within a given hospital setting, rather than application of 
a tested and ‘proven effective’ universal approach. While the types of research forwarded 
by hierarchies of evidence are potentially helpful, forms of evidence that seek to understand 
(rather than control for) social context may be equally (or more) useful.  
Social norms and behaviours are integral to illness and to the management of illness 
(Helman and Helman, 2007). Many health policies must therefore take into account aspects 
of social or behavioural change to achieve optimal results. This provides another challenge 
to reductionist applications of a hierarchy of evidence, which value experimental trials 
(which typically are of single interventions) with an expected generalisable causal effect. In 
social interventions, often the mechanism of effect is contextually determined, and, as such, 
the mechanism through which an intervention works in one place, or population, or time, 
may be very different elsewhere (Cartwright, 2011, Pawson and Tilley, 1997). For example, 
increasingly the HIV prevention field has been focussing upon structural interventions to 
reduce behavioural HIV risk (Auerbach et al., 2011, Gupta et al., 2008), with recent 
discussions on whether financially based interventions – such as cash transfers or access to 
credit (e.g. microcredit loans) - are ‘effective’ for preventing HIV (Baird et al., 2012, Kohler 
and Thornton, 2010, Medlin and De Walque, 2008, Hall, 2006, Pronyk et al., 2006). 
However, the social nature of sexual risk behaviour (and any links is has to access to 
financial resources) means that a financial intervention showing an impact in one area may 
work in very different ways elsewhere. So while an intervention that provides financial 
assistance may lead to reduced HIV-related risk when given to poorer women who rely on 
transactional sex to make ends meet, the exact same intervention may increase risk taking 
in another setting - for instance if given to women who never relied on transactional sex, 
but who end up using the funds to travel and as a result end up engaging in wider sexual 
networking. Similarly provision of HIV/AIDS information has been studied as if there is a 
single mechanism through which information may affect behaviour, yet an information 
campaign that inspires fear in one setting to achieve behaviour change might inspire 
laughter or disgust in another, working (or not working) through very different mechanisms 
of effect.  
Meta-analysis is often held up to be at the top of the evidence hierarchy, yet the above 
example illustrates how unfit it can be for the purpose of guiding policy action if the 
mechanism of effect of an intervention changes according to local contextual factors. If a 
meta-analysis combined trials of cash transfer interventions for HIV prevention and included 
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a population for whom it averted transactional sex alongside a population for whom it 
promoted wider sexual networking, the final conclusion might erroneously be ‘cash 
transfers show flat (or conflicting) results’. Yet a more accurate (and more useful) conclusion 
might be that ‘cash transfers work for some groups in some contexts, and do not work for 
other groups in other contexts’. To draw this conclusion, however, requires different 
evidence – not just an increasingly large sample on whom the intervention has been trialled, 
but ‘realistic evaluation’ evidence (or a ‘realist’ review) that investigates how social context 
affects the mechanism of intervention to achieve an outcome or impact (Pawson et al., 
2005, Pawson and Tilley, 1997). This might include ethnographic evidence or in-depth 
interviewing in target communities in this example, for instance, in addition to any trial of 
effectiveness (cf. Bonnell et al. 2012 for an attempt to integrate these approaches). As 
Nancy Cartwright has explained “[f]or policy and practice we do not need to know ‘it works 
somewhere’. We need evidence for ‘it-will-work-for-us’.” (Cartwright, 2011: 1401). Context 
specific, and therefore inherently social, factors can therefore be seen as worthy and 
necessary of study – and a body of evidence particularly necessary to inform policies of this 
nature. 
 
From a hierarchy to  appropriateness 
For these reasons detailed above, public health (and other social policy) decision makers 
may find that a simple application of the hierarchy of evidence does not best serve their 
policy goals. In order to best apply evidence to policy, decision makers need to understand 
both the multiple decision criteria on which the policy decision is based, as well as the 
nature of the interventions they aim to implement to achieve their policy goals. If a 
proposed intervention has purely clinical aspects, and the only policy criteria at stake is 
morbidity, mortality, or cost-effective criteria, then the evidentiary best practice might 
indeed be to follow hierarchies of evidence from epidemiology and clinical medicine. If 
aspects of the health problem or proposed solution are social or behavioural, or if other 
social outcomes are an important part of the policy decision, then different sets of evidence 
can be sought out.  
In order for the appropriate evidence to be chosen, therefore, policy makers also need to 
play an active role. The underlying goals and premises of the policy need to be well-
established before the evidence can be chosen. This includes an explicit articulation of 
which factors are considered to take primacy in making decision (e.g. to what extent do 
economic considerations overweigh the benefits of the proposed intervention, to what 
extent does positive impact in a small sub-population justify a large-scale or costly change 
etc). Pinpointing the goals of the policy as explicitly and narrowly as possible ensures that 
instead of being daunted by large amounts of varied research, a narrower, appropriate and 
specific set of research can be accessed.  
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What is required, then, is both an explicit understanding of the nature of the policy question 
(what is it that is needed from the evidence), and a more nuanced understanding of what 
might constitute ‘good’ evidence for particular policy concerns. 
 
Appropriate, but rigorous, evidence  
Once the appropriate evidence has been determined, the various forms of evidence can be 
assessed for quality. The validity and rigour of different forms of evidence is established by 
different methodological criteria. As noted, current hierarchies of evidence look at the idea 
of good research through a narrow perspective which emphasise qualities that are 
appropriate for the research of context-free and universal biological or physical properties 
with an expected direct causal effect. This way of understanding rigour is useful for most 
clinical evidence of biological or surgical actions and treatments. It is also applicable for 
some epidemiological research, which seeks to understand risk factors, or the success of 
population-level interventions. In contrast, as demonstrated above, policy makers may also 
need to access those forms of evidence which derive from the very different realities of the 
social and political world. 
Each research or methodological tradition (i.e. experiments, interviews, observations etc.) is 
underpinned by its own standards of quality and validity. Awareness of each is important 
because different research methodologies seek to understand different parts of the process 
of health and healthcare. There is a fundamental difference in trying to understand the 
biological, the individual, the social, the economic and the political, and each produce 
research through very different lenses. Since this is the case, methodological traditions are 
accompanied by different research protocols and different forms of rigour. 
For example, survey research may be useful when evaluating the opinions of communities 
around social acceptability. When looking at survey research, the quality of evidence should 
be evaluated in a way specific to that research tradition. This would include an assessment 
of statistical representativeness, including the sample size and variation. Rigorous research 
in the context of surveys would also include studies which exhibit internal validity – the 
questions asked in the survey actually measure and reflect the aims of the research – and 
also external validity – that the results are generalisable to the target research population, 
achieved by making sure that the survey instrument is properly representative. There are 
other ways in which a survey can maximise reliability, for example through triangulation, in 
asking research subjects several questions that are aimed to provide data on a singular 
research question (i.e. to make sure that, even when the same subject/question is broached 
through different wording or emphasis, the results remain consistent). Controlling for the 
conditions in which the survey is performed will also help to maximise validity. For example, 
research subjects should ideally by surveyed in similar environments (i.e. all at their homes, 
all at their GPs surgery etc.), in identical ways (in terms of the process of administering the 
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survey, the emphasis or tone of voice in the case of verbal surveys etc.). These mechanisms 
are set out to control the influence of external factors wherever possible.   
Observational or ethnographic research may be useful to policy makers in understanding 
the cultural context that surrounds a certain policy room (such as the A&E example above), 
or to access the perspectives of a small but important community of people. So, for 
instance, if a policy problem calls for a better understanding of the way in which breast 
cancer patients make sense of their diagnosis and prognosis (for example, in order to 
produce policy that bettered the experience of such patients), one way in which this could 
be done is through observing the communication of diagnosis (see Gross, 2009 in the 
context of brain cancer diagnosis). Observational and ethnographic studies emphasise the 
importance of understanding processes through the perspective of key participants 
(Hammersley and Atkinson, 1989). Since context and meaning are so strongly tied to this 
research tradition, these are emphasised in the understanding of evidentiary rigour for 
these methods. High quality observational and ethnographic research is signified by the 
researchers’ immersion in the research context and the ability of the research to gain insider 
insight into processes. One way in which the researcher can know this is achieved is through 
feeding back their findings to the research participants, as a method of seeing if the account 
of the research is valid to those involved. Another criteria of rigour and validity in terms of 
this research tradition is the idea of reflexivity – that is, since the researcher is immersed in 
the context, it is important for the researcher to be able to explicate their own values or 
viewpoints may have impacted upon their understanding of the process (Davies, 2008). 
Unlike a survey technique, then (which attempts to minimise external influences in some 
sense), it is acknowledged that the researcher is necessarily ‘close’ to the process, and 
validity is accounted in relation to the ability of the researcher to accurately articulate the 
process. 
Interviewing methodologies, on the other hand, occupy a broad spectrum between survey 
and ethnographic approaches. Interviewing techniques can be useful for policy makers 
where the in-depth opinions and viewpoints of a small number of individuals is useful. For 
instance, when looking at the breast cancer diagnosis as given above, it might be 
appropriate to interview the oncologists or GPs involved in the communication of diagnosis 
to try and access their perspective on the process and impact on patients. For the example 
of cash-transfers for HIV prevention above, interviews might be needed to identify how 
access to cash affected specific risk behaviours, and for which sub-groups the intervention 
appeared to be more or less successful. These insights could be produced through one of 
many forms of interviewing. These range from structured techniques (where questions are 
set, and the same questions are asked of each interviewee) to semi-structured interviews 
(where interviewers are bound to the set of core problems, but may ask slightly different 
questions to different participants in order to access data surrounding this core set of 
problems) to unstructured interviews (where the course of the interview is tailored to each 
participant, not pre-determined, and allowed to follow the course of the conversation 
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between the interviewer and interviewee) (Silverman, 2004, 2009). Since these forms of 
interviewing are diverse, methodological rigour is assessed slightly differently in each case. 
In the case of strongly structured interviews, ideas of validity are closer to that of survey 
methods (i.e. in the context of reliability and maintaining a regimented process). Strongly 
unstructured interviews emphasise forms of validity more close to ethnography (i.e. how 
well does the data reflect the experiences of the research participants). Other forms of 
rigour in the context of interviews include the idea of ‘saturation’ – rigorous interview 
protocols conduct interviews until no ‘new’ data appears (Bowen, 2008). Equally, 
conclusions must be based upon multiple interviews, and not simply extrapolated from a 
few cases.  
Ultimately, when selecting evidence, what is essential is for decision makers to firstly 
identify the types of information they need on which to base their decision (their decision 
criteria) after which, the appropriate evidence can be judged and evaluated. Each research 
tradition comes with its own criteria for establishing ‘rigour’. Once the appropriate evidence 
base is selected, these assessments of rigour can be applied as according to the criteria set 
out by research of that tradition. 
 
Conclusion 
This paper has been developed within a research programme concerned with improving the 
use of research evidence in health policy. However, to understand how to do this, a key 
question revolves around what ‘good’ evidence for decision making looks like. The multiple 
social aspects of any health problem or intervention are integral to the management of 
illness and achieving public health goals. Due to the fundamentally social nature of health 
and illness, and the contextual realities of healthcare and health policy, notions of 
evidentiary validity derived from clinical medicine and the evidence-based medicine 
movement do not necessarily extend to all the questions posed in the formation of effective 
public health policy. The Western medical ideal sees research and causality as divorced from 
social consequences. However, on the contrary, health and illness are fundamentally socially 
embedded – and questions surrounding both the origins of health problems, as well as the 
management of health conditions are typically socio-political in nature. 
We argue that ‘good’ evidence should not simply be equated to a particular position within 
the hierarchy of evidence of the natural sciences, which specifically relates to effectiveness 
studies. Rather, we argue for a conceptualisation which sees good evidence for policy as 
that evidence which is appropriate to the multiple decision criteria being considered. Once 
these decision criteria are elucidated, and evidence bodies identified, then the quality and 
rigour of each evidence type can further be evaluated before the ultimate policy judgement 
is made. The figure below attempts to provide a simple schematic for this process: 
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There are almost no decisions at a political level that simply require an analysis of 
epidemiological or clinical evidence. Every decision has opportunity costs, and most health 
issues touch on a range of important concerns beyond morbidity and mortality – such as 
economic impact (not just cost-effectiveness), fairness and equality, solidarity and justice, or 
human rights. Many health interventions further involve social norms and behaviours, or 
government actions over which the population may have moral or ideological concerns 
(such as views about state control versus individual freedom, or the ‘right’ and ‘wrong’ way 
to behave). The vast majority of these issues cannot, and should not, be addressed with 
evidence that easily fits into a single hierarchy. For public health actors to achieve their 
policy goals – goals such as improvements in population health, reductions in avoidable 
morbidity and mortality, and decreases in health inequalities – they must ensure not only 
that they use evidence to guide their decisions, but that they use the right evidence to do 
so. 
  
STEP 1: Identify the multiple decision criteria 
STEP 2: Identify appropriate tpye of evidence for 
each criteria 
STEP 3: Review appropraite evidence 
STEP 4: Apply evidence-specific quality 
evaluation 
STEP 5: Integrate the outcomes of this process 
into the decision judgement 
Figure 1: Steps involved in the selection and use of appropriate evidence. 
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